The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.
Multiple Functions of Endocannabinoid Signaling in the Brain
Open accessAbstract
Despite being regarded as a hippie science for decades, cannabinoid research has finally found its well-deserved position in mainstream neuroscience. A series of groundbreaking discoveries revealed that endocannabinoid molecules are as widespread and important as conventional neurotransmitters such as glutamate or GABA, yet they act in profoundly unconventional ways. We aim to illustrate how uncovering the molecular, anatomical, and physiological characteristics of endocannabinoid signaling has revealed new mechanistic insights into several fundamental phenomena in synaptic physiology. First, we summarize unexpected advances in the molecular complexity of biogenesis and inactivation of the two endocannabinoids, anandamide and 2-arachidonoylglycerol. Then, we show how these new metabolic routes are integrated into well-known intracellular signaling pathways. These endocannabinoid-producing signalosomes operate in phasic and tonic modes, thereby differentially governing homeostatic, short-term, and long-term synaptic plasticity throughout the brain. Finally, we discuss how cell type– and synapse-specific refinement of endocannabinoid signaling may explain the characteristic behavioral effects of cannabinoids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is widely accepted28 that CCK-positive cells in the rodent show selectively high expression of cannabinoid receptors and are involved in perisomatic inhibition.”
From Transcriptomic and morphophysiological evidence for a specialized human cortical GABAergic cell type (2018) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Glycine potentiates the NMDA response in cultured mouse brain neurons
Johnson, J. W., & Ascher, P. (1987) · Nature · doi:10.1038/325529a0 · Cited by 3,182
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 2×
“1C-D) (Devane et al., 1988; Bidaut-Russell et al., 1990).”
BackgroundIsolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Research works printed but not linked: 1
- Gaoni Y, 1967, Tetrahedron Lett., 12, 1109
Cited by
Sorted by citations
Items 201–300 of 675
Sagar, K. A., & Gruber, S. A. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13990 · Cited by 36
The Endocannabinoid System: A New Treatment Target for Obsessive Compulsive Disorder?
Kayser, R. R., Snorrason, Í., Haney, M., Lee, F. S., & Simpson, H. B. (2019) · Cannabis and Cannabinoid Research · doi:10.1089/can.2018.0049 · Cited by 36
Endocannabinoid signaling in synaptic function
Noriega‐Prieto, J. A., Kofuji, P., & Araque, A. (2022) · Glia · doi:10.1002/glia.24256 · Cited by 36
Sachser, R. M., Crestani, A. P., Quillfeldt, J. A., Souza, T. M. E., & Alvares, L. D. O. (2015) · Learning & Memory · doi:10.1101/lm.039891.115 · Cited by 36
Small-Volume Analysis of Cell–Cell Signaling Molecules in the Brain
Romanova, E. V., Aerts, J. T., Croushore, C. A., & Sweedler, J. V. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.145 · Cited by 35
The endocannabinoid 2-arachidonoylglycerol regulates oligodendrocyte progenitor cell migration
Sanchez-Rodriguez, M. A., Gómez, O., Esteban, P. F., García‐Ovejero, D., & Molina‐Holgado, E. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.006 · Cited by 35
Possible therapeutic applications of cannabis in the neuropsychopharmacology field
Fernández‐Ruíz, J., Galve‐Roperh, I., Sagredo, O., & Guzmán, M. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.01.013 · Cited by 35
Endocannabinoid system and its modulation of brain, gut, joint and skin inflammation
Osafo, N., Yeboah, K. O., & Antwi, A. O. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06366-1 · Cited by 35
Hicks, J. W., Parkes, J., Sadovski, O., Tong, J., Houle, S., Vasdev, N., & Wilson, A. A. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2013.04.008 · Cited by 35
DeVuono, M. V., Nashed, M. G., Sarikahya, M. H., Kocsis, A., Lee, K., Vanin, S., Hudson, R., Lonnee, E. P., Rushlow, W. J., Hardy, D. B., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106588 · Cited by 34
Janssen, F. J., Deng, H., Baggelaar, M. P., Allarà, M., van der Wel, T., den Dulk, H., Ligresti, A., van Esbroeck, A. C. M., McGuire, R., Marzo, V. D., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500681z · Cited by 34
Spiacci, G. B. L., Antero, L. S., dos Reis, D. G., Lisboa, S. F. D. S., & Resstel, L. B. M. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.08.010 · Cited by 34
Crombie, K. M., Privratsky, A. A., Schomaker, C. M., Heilicher, M. O., Ross, M. C., Sartin‐Tarm, A., Sellnow, K. A., Binder, E. B., James, G. A., & Cisler, J. M. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102922 · Cited by 33
Rice, L. J., Cannon, L., Dadlani, N., Cheung, M. M. Y., Einfeld, S., Efron, D., Dossetor, D. R., & Elliott, E. J. (2023) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-023-02169-w · Cited by 33
Zádor, F., Nagy-Grócz, G., Kékesi, G., Dvorácskó, S., Szűcs, E., Tömböly, C., Horváth, G., Benyhe, S., & Vécsei, L. (2019) · Molecules · doi:10.3390/molecules24203709 · Cited by 33
Circulating endocannabinoids and prospective risk for depression in trauma-injury survivors
Fitzgerald, J. M., Chesney, S. A., Lee, T. S., Brasel, K. J., Larson, C. L., Hillard, C. J., & deRoon‐Cassini, T. A. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100304 · Cited by 32
Endocannabinoid System and Alcohol Abuse Disorders
Basavarajappa, B. S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21737-2_6 · Cited by 32
Cannabinoids in Chronic Pain Management: A Review of the History, Efficacy, Applications, and Risks
Johnson, B. W., Strand, N. H., Raynak, J., Jara, C., Habtegiorgis, K., Hand, B. A., Hong, S., & Maloney, J. A. (2025) · Biomedicines · doi:10.3390/biomedicines13030530 · Cited by 31
Endocannabinoid Modulation of Stimulus-Specific Adaptation in Inferior Colliculus Neurons of the Rat
Valdés‐Baizabal, C., Parras, G. G., Ayala, Y. A., & Malmierca, M. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-07460-w · Cited by 31
Endocannabinoid-serotonin systems interaction in health and disease
Colangeli, R., Teskey, G. C., & Giovanni, G. D. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.01.003 · Cited by 31
A review of the effects of acute and chronic cannabinoid exposure on the stress response
Glodosky, N. C., Cuttler, C., & McLaughlin, R. J. (2021) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2021.100945 · Cited by 31
Zhu, D., Zhang, J., Hashem, J., Gao, F., & Chen, C. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02701-4 · Cited by 31
Yuan, S., & Burrell, B. D. (2013) · Journal of Neurophysiology · doi:10.1152/jn.00170.2013 · Cited by 31
Melis, M., Greco, B., & Tonini, R. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12501 · Cited by 31
Cannabinoids for pediatric epilepsy? Up in smoke or real science?
Filloux, F. M. (2015) · PubMed Central · doi:10.3978/j.issn.2224-4336.2015.10.03 · Cited by 30
Wang, F., Han, J., Higashimori, H., Wang, J., Liu, J., Li, T., Yang, Y., Dong, H., Zhang, X., & Xiong, L. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18755661 · Cited by 30
Holley, S. M., Galvan, L., Kamdjou, T., Dong, A., Levine, M. S., & Cepeda, C. (2019) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2019.00014 · Cited by 30
Río, I. B., Puente, N., Peñasco, S., Rico, I., Gutiérrez‐Rodrίguez, A., Elezgarai, I., Ramos, A., Reguero, L., Gerrikagoitia, I., Christie, B. R., et al. (2017) · Addiction Biology · doi:10.1111/adb.12585 · Cited by 30
Cannabinoid Receptors Modulate Neuronal Morphology and AnkyrinG Density at the Axon Initial Segment
Tapia, M., Dominguez, A. L., Zhang, W., del Puerto, A., Ciorraga, M., Benítez, M. J., Guaza, C., & Garrido, J. J. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00005 · Cited by 30
Malcher‐Lopes, R. (2014) · Revista da Biologia · doi:10.7594/revbio.13.01.07 · Cited by 29
Pryce, G., Visintin, C., Ramagopalan, S. V., Al‐Izki, S., Faveri, L. E. D., Nuamah, R. A., Mein, C. A., Montpetit, A., Hardcastle, A. J., Kooij, G., et al. (2013) · The FASEB Journal · doi:10.1096/fj.13-239442 · Cited by 29
Oultram, J. M. J., Pegler, J. L., Bowser, T. A., Ney, L. J., Eamens, A. L., & Grof, C. P. L. (2021) · Biomedicines · doi:10.3390/biomedicines9030234 · Cited by 30
Ten-Blanco, M., Flores, Á., Pereda-Pérez, I., Piscitelli, F., Izquierdo-Luengo, C., Cristino, L., Romero, J., Hillard, C. J., Maldonado, R. J., Marzo, V. D., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112925 · Cited by 29
Circulating endocannabinoids and psychological outcomes in women with PTSD
Botsford, C., Brellenthin, A. G., Cisler, J. M., Hillard, C. J., Koltyn, K. F., & Crombie, K. M. (2022) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2022.102656 · Cited by 29
Andresen, M. C., Fawley, J. A., & Hofmann, M. E. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00191 · Cited by 30
Santana, F., Sierra, R. O., Haubrich, J., Crestani, A. P., Duran, J. M., Cassini, L. F., Alvares, L. D. O., & Quillfeldt, J. A. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2015.11.016 · Cited by 29
Boullon, L., Finn, D. P., & Llorente‐Berzal, A. (2021) · Frontiers in Pain Research · doi:10.3389/fpain.2021.673638 · Cited by 28
Endocannabinoid Modulation of Nucleus Accumbens Microcircuitry and Terminal Dopamine Release
Covey, D. P., & Yocky, A. G. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.734975 · Cited by 28
Palumbo, J., Thomas, B. F., Budimirovic, D. B., Siegel, S. J., Tassone, F., Hagerman, R. J., Faulk, C. D., O’Quinn, S., & Sebree, T. B. (2023) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-023-09475-z · Cited by 28
Gobira, P. H., de Aguiar, D. C., & Moreira, F. A. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.05.013 · Cited by 28
Borgmeyer, M., Coman, C., Has, C., Schött, H.-F., Li, T., Westhoff, P., Cheung, H. Y. F., Hoffmann, N., Yuanxiang, P., Behnisch, T., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109797 · Cited by 27
CB2 Receptor Involvement in the Treatment of Substance Use Disorders
Navarrete, F., García‐Gutiérrez, M. S., Gasparyan, A., Navarro, D., & Manzanares, J. (2021) · Biomolecules · doi:10.3390/biom11111556 · Cited by 27
Trautmann, S. M., & Sharkey, K. A. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.10.002 · Cited by 27
Ma, L., Wang, L., Yang, F., Meng, X., Wu, C., Ma, H., & Jiang, W. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12302 · Cited by 27
Brain endocannabinoid signaling exhibits remarkable complexity
Gorzkiewicz, A., & Szemraj, J. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.06.012 · Cited by 26
Puente, N., Río, I. B., Achicallende, S., Nahirney, P. C., & Grandes, P. (2019) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3145 · Cited by 26
Biomarkers of the Endocannabinoid System in Substance Use Disorders
Navarrete, F., García‐Gutiérrez, M. S., Gasparyan, A., Navarro, D., Lopez‐Picon, F. R., Morcuende, Á., Femenía, T., & Manzanares, J. (2022) · Biomolecules · doi:10.3390/biom12030396 · Cited by 26
Chemical Tools for Studying Lipid-Binding Class A G Protein–Coupled Receptors
Cooper, A. G., Singh, S., Hook, S. M., Tyndall, J. D. A., & Vernall, A. J. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013243 · Cited by 26
Luce, V., Fernández‐Solari, J., Rettori, V., & Laurentiis, A. D. (2013) · Regulatory Peptides · doi:10.1016/j.regpep.2013.12.004 · Cited by 26
Gomes‐de‐Souza, L., de Oliveira, L. L., Benini, R., Rodella, P., Ferreira, W. C., & Crestani, C. C. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13560 · Cited by 26
The role of cannabinoid 1 receptor expressing interneurons in behavior
Brown, J. A., Horváth, S., Garbett, K. A., Schmidt, M. J., Everheart, M., Gellért, L., Ebert, P. J., & Mirnics, K. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.001 · Cited by 25
Péterfi, Z., Farkas, I., Denis, R., Farkas, E., Uchigashima, M., Füzesi, T., Watanabe, M., Lechan, R. M., Liposits, Z., Luquet, S. H., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.08.007 · Cited by 25
Chronic Pain and the Endocannabinoid System: Smart Lipids – A Novel Therapeutic Option?
Zieglgänsberger, W., Brenneisen, R., Berthele, A., Wotjak, C. T., Bandelow, B., Tölle, T. R., & Lutz, B. (2022) · Medical Cannabis and Cannabinoids · doi:10.1159/000522432 · Cited by 25
How do Glial Cells Contribute to Motor Control?
Christensen, R. K., Petersen, A. V., & Perrier, J. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990384 · Cited by 25
Molecular Mechanisms of Cannabis Signaling in the Brain
Ronan, P. J., Wongngamnit, N., & Beresford, T. P. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.10.002 · Cited by 25
Murillo‐Rodríguez, E., Palomero‐Rivero, M., Millán‐Aldaco, D., & Marzo, V. D. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.11.007 · Cited by 25
Synaptic effects of cannabinoids
Benarroch, E. E. (2014) · Neurology · doi:10.1212/wnl.0000000000001013 · Cited by 25
Naturalistic exploratory study of the associations of substance use on ADHD outcomes and function
MacDonald, B., & Sadek, J. R. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03263-6 · Cited by 24
Sisk, L. M., Rapuano, K. M., Conley, M. I., Greene, A. S., Horien, C. L., Rosenberg, M. D., Scheinost, D., Constable, R. T., Glatt, C. E., Casey, B. J., et al. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24946 · Cited by 24
Phytocannabinoids, the Endocannabinoid System and Male Reproduction
Lim, J., Squire, E., & Jung, K. (2022) · The World Journal of Men s Health · doi:10.5534/wjmh.220132 · Cited by 24
Rivera, P., Blanco, E., Bîndilă, L., Alén, F., Vargas, A., Rubio, L., Pavón, F. J., Serrano, A., Lutz, B., de Fonseca, F. R., et al. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00379 · Cited by 24
Role of the Endocannabinoid System in the Neuroendocrine Responses to Inflammation
Laurentiis, A. D., Araújo, H. A., & Rettori, V. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140130212957 · Cited by 24
Brain Molecules and Appetite: The Case of Oleoylethanolamide
Sarro-Ramírez, A., Sanchez-Lopez, D., Tejeda-Padrón, A., Frias, C., Rae, J. Z., & Murillo‐Rodríguez, E. (2013) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524911313010010 · Cited by 24
Pharmacological effects of cannabinoids on learning and memory in Lymnaea
Sunada, H., Watanabe, T., Hatakeyama, D., Lee, S. M., Forest, J., Sakakibara, M., Ito, E., & Lukowiak, K. (2017) · Journal of Experimental Biology · doi:10.1242/jeb.159038 · Cited by 24
Pirbhoy, P. S., Jonak, C. R., Syed, R., Argueta, D. A., Perez, P. A., Wiley, M. B., Hessamian, K., Lovelace, J. W., Razak, K. A., DiPatrizio, N. V., et al. (2021) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-021-09394-x · Cited by 24
Gomes-de-Souza, L., Costa-Ferreira, W., Mendonça, M. M., Xavier, C. H., & Crestani, C. C. (2021) · Scientific Reports · doi:10.1038/s41598-021-95401-z · Cited by 23
Gado, F., Mohamed, K. A., Meini, S., Ferrisi, R., Bertini, S., Digiacomo, M., D’Andrea, F., Stevenson, L., Laprairie, R. B., Pertwee, R. G., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113116 · Cited by 23
Bueno-Fernández, C., Pérez-Rando, M., Alcaide, J., Coviello, S., Sandi, C., Castillo-Gómez, E., & Nácher, J. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100322 · Cited by 23
Vinogradova, L. V., & van Rijn, C. M. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.12.002 · Cited by 23
Neuhofer, D., Lassalle, O., & Manzoni, O. J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00398 · Cited by 23
Navarro-Romero, A., Galera-López, L., Ortiz‐Romero, P., Llorente‐Ovejero, A., Reyes‐Ramírez, L. D. L., de Tena, I. B., García-Elías, A., Mas‐Stachurska, A., Reixachs‐Solé, M., Pastor, A., et al. (2022) · eLife · doi:10.7554/elife.72560 · Cited by 22
Kovács, A., Bordás, C., Bı́ró, T., Hegyi, Z., Antal, M., Szűcs, P., & Pál, B. Z. (2016) · Brain Structure and Function · doi:10.1007/s00429-016-1214-0 · Cited by 22
Cannabinoids in Health and Disease
Meccariello, R., & Chianese, R. (2016) · InTech eBooks · doi:10.5772/61595 · Cited by 22
Cannabidiol for the Treatment of Drug-Resistant Epilepsy in Children: Current State of Research
Evans, V., DeMarse, T. B., Febo, M., Johnson, C. R., Carney, P. R., & Anderson, C. L. (2017) · Journal of Pediatric Neurology · doi:10.1055/s-0037-1598109 · Cited by 22
Khatri, D., Laroche, G., Grant, M. L., Jones, V. M., Vetreno, R. P., Crews, F. T., & Mukhopadhyay, S. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13608 · Cited by 22
Chronic pain and cannabinoids. Great expectations or a christmas carol
Pascual, D., Sánchez-Robles, E., García, M. M., & Goicoechea, C. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.033 · Cited by 22
Río, I. B., Puente, N., Mimenza, A., Ramos, A., Serrano, M., Lekunberri, L., Gerrikagoitia, I., Christie, B. R., Nahirney, P. C., & Grandes, P. (2020) · The Journal of Comparative Neurology · doi:10.1002/cne.25098 · Cited by 22
Axonal CB1 Receptors Mediate Inhibitory Bouton Formation via cAMP Increase and PKA
Liang, J., Kruijssen, D. L. H., Verschuuren, A. C. J., Voesenek, B. J. B., Benavides, F. F. W., González, M. S., Ruiter, M., & Wierenga, C. J. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0851-21.2021 · Cited by 22
Khodamoradi, M., Tirgar, F., Ghazvini, H., Rafaiee, R., Tamijani, S. M. S., Karimi, N., Yadegari, A., Siahposht-Khachaki, A., & Akhtari, J. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136634 · Cited by 22
The endocannabinoid system, a novel and key participant in acupuncture’s multiple beneficial effects
Hu, B., Bai, F., Xiong, L., & Wang, Q. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.006 · Cited by 22
p21-activated kinase 1 restricts tonic endocannabinoid signaling in the hippocampus
Xia, S., Zhou, Z., Leung, C., Zhu, Y., Pan, X., Qi, J., Morena, M., Hill, M. N., Xie, W., & Jia, Z. (2016) · eLife · doi:10.7554/elife.14653 · Cited by 21
Janssen, F. J., Baggelaar, M. P., Hummel, J. J. A., Overkleeft, H. S., Cravatt, B. F., Boger, D. L., & van der Stelt, M. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01627 · Cited by 21
Effects of centrally administered endocannabinoids and opioids on orofacial pain perception in rats
Zubrzycki, M., Janecka, A. E., Liebold, A., Ziegler, M., & Zubrzycka, M. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13970 · Cited by 21
Interaction of Cannabis Use and Aging: From Molecule to Mind
Yoo, H. B., DiMuzio, J. M., & Filbey, F. M. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1665218 · Cited by 21
Mashhoon, Y., Sagar, K. A., & Gruber, S. A. (2019) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2019.08.004 · Cited by 21
Kondev, V., Winters, N. D., & Patel, S. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.007 · Cited by 21
Endocannabinoid signaling modulates neurons of the pedunculopontine nucleus (PPN) via astrocytes
Kőszeghy, Á., Kovács, A., Bı́ró, T., Szűcs, P., Vincze, J., Hegyi, Z., Antal, M., & Pál, B. Z. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0842-5 · Cited by 21
Epigenetic Effects of Drugs of Abuse
Heinbockel, T., & Csoka, A. B. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15102098 · Cited by 21
Gomes‐de‐Souza, L., Bianchi, P., Ferreira, W. C., Tomeo, R. A., Cruz, F. C., & Crestani, C. C. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110284 · Cited by 21
Integrating Endocannabinoid Signalling In Depression
Rana, T., Behl, T., Sehgal, A., Mehta, V., Singh, S., Kumar, R., & BUNGAU, S. G. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01774-7 · Cited by 20
Endocannabinoid signaling in oligodendroglia
Molina‐Holgado, E., Esteban, P. F., Arévalo‐Martín, Á., Moreno‐Luna, R., Molina‐Holgado, F., & García‐Ovejero, D. (2022) · Glia · doi:10.1002/glia.24180 · Cited by 20
CB1R blockade unmasks TRPV1-mediated contextual fear generalization in female, but not male rats
Huckleberry, K. A., Calitri, R., Li, A. J., Mejdell, M., Singh, A., Bhutani, V., Laine, M. A., Nastase, A. S., Morena, M., Hill, M. N., et al. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01650-z · Cited by 19
Amyotrophic Lateral Sclerosis and Pain: A Narrative Review from Pain Assessment to Therapy
Pota, V., Sansone, P., Sarno, S. D., Aurilio, C., Coppolino, F., Barbarisi, M., Barbato, F., Fiore, M., Cosenza, G., Passavanti, M. B., et al. (2024) · Behavioural Neurology · doi:10.1155/2024/1228194 · Cited by 19
Sagar, K. A., & Gruber, S. A. (2025) · CNS Drugs · doi:10.1007/s40263-024-01148-2 · Cited by 19
Sárvári, M., Kocsis, P., Deli, L., Gajári, D., Dávid, S., Pozsgay, Z., Hegedűs, N., Tihanyi, K., & Liposits, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097651 · Cited by 19
Cooper, A. G., Oyagawa, C. R. M., Manning, J. J., Singh, S., Hook, S. M., Grimsey, N. L., Glass, M., Tyndall, J. D. A., & Vernall, A. J. (2018) · MedChemComm · doi:10.1039/c8md00448j · Cited by 19
Bedse, G., Centanni, S. W., Winder, D. G., & Patel, S. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14159 · Cited by 19
Opioid and Endocannabinoid System in Orofacial Pain
Zubrzycki, M., Stasiołek, M., & Zubrzycka, M. (2019) · Physiological Research · doi:10.33549/physiolres.934159 · Cited by 19
Endocannabinoids reduce cerebral damage after hypoxic–ischemic injury in perinatal rats
Lara‐Celador, I., Castro-Ortega, L., Alvarez, A. A., Goñi‐de‐Cerio, F., Prieto, J. L., & Hilario, E. (2012) · Brain Research · doi:10.1016/j.brainres.2012.07.045 · Cited by 19
Cooper, A. G., Macdonald, C. E., Glass, M., Hook, S. M., Tyndall, J. D. A., & Vernall, A. J. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.11.076 · Cited by 19
Metadata
- Authors
- Katona, I., & Freund, T. F.
- Affiliations
- HUN-REN Institute of Experimental Medicine (HU)
- Venue
- Annual Review of Neuroscience
- Publisher
- Annual Reviews
- Published
- 2012-07-21
- Volume
- 35
- Issue
- 1
- Pages
- 529-558
- ISSN
- 0147-006X (ISSN-L)
- 1545-4126
- PMC
- PMC4273654
- OpenAlex
- W2168499817
- Cited by
- 630
- References
- 183
- Citations by year
- 2026: 39 · 2025: 35 · 2024: 29 · 2023: 44 · 2022: 53 · 2021: 60 · 2020: 56 · 2019: 32 · 2018: 50 · 2017: 57 · 2016: 34 · 2015: 45 · 2014: 43 · 2013: 41 · 2012: 11
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annual Review of Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Wellcome Trust (090946)
- National Institute of Mental Health (R01MH054671, MH54671)
- National Institute of Neurological Disorders and Stroke (R37NS030549, R01NS030549, NS30549)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Keywords
- endocannabinoid signaling, anandamide, 2-arachidonoylglycerol, signalosome, synaptic plasticity, intracellular signaling, cell type-specific signaling, brain
- MeSH terms
- Animals, Arachidonic Acids, Behavior, Animal, Brain, Glycerides, Humans, Ligands, Models, Neurological, Synaptic Transmission, Neuronal Plasticity, Signal Transduction, Receptors, Cannabinoid, Polyunsaturated Alkamides, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review